Oncolix Inc. (fka ONCX)

[DayDreeming]

Mr. Michael T. Redman, B.A (Biology), M.B.A., has been Chairman, President and Principal Financial Officer of Advanced Environmental Petroleum Producers, Inc. since January 19, 2017 and has been Chief Executive Officer since April 6, 2017. Mr. Redman has been Chief Executive Officer of Oncolix, Inc. since November 2006. Prior to forming Oncolix, Mr. Redman co-founded Opexa Pharmaceuticals, Inc. in February 2001 and served as its Chief Executive Officer & President. He served as the Chief Executive Officer of Bone Medical Ltd. from February 28, 2005 to November 7, 2005. Previously, he served as President, Chief Executive Officer and a Director at Opexa Pharmaceuticals. His career combines sales, marketing, business and commercial development experience gained over 25 years in the pharmaceutical and biotechnology industry. Mr. Redman also served as Vice-President of Corporate Development at Aronex Pharmaceuticals, Inc. and as Vice-President of Business Development at Zonagen, Inc. He was formerly Vice-President of Marketing & Sales at Biovail. He has a distinguished track record in the area of licensing, sales and marketing and has consummated licensing deals with many large pharmaceutical companies, both domestic and international. He was employed at Repros Therapeutics Inc. He has been a Director of Advanced Environmental Petroleum Producers, Inc. since April 6, 2017. He serves as Director of Opexa Pharmaceuticals, Inc. and Oncolix, Inc. He also serves as a director of the Licensing Executive's Society. He served as Director of Bone Medical Ltd. from February 28, 2005 to November 7, 2005. Mr. Redman has work experience in large pharmaceutical companies, including Monsanto and American Home Products. Mr. Redman received his B.A. in Biology from the University of Missouri and a Masters in Business Administration from the University of Phoenix.

Source:
https://www.bloomberg.com/research/stocks/private/person.asp?personId=200766&privcapId=317012132